Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer

Clinical trial NCT00320385 · COMPLETED

Trial details

NCT number: NCT00320385
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2005-11-01
Primary completion: 2007-06-01
Enrollment: 296

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.